ADVERTISEMENT
ADVERTISEMENT
This author has not written his bio yet.
But we are proud to say that Christian Kähler contributed 10 entries already.
Jena-based InflaRx has reached a significant milestone with the European Commission’s approval of GOHIBIC (Vilobelimab), a novel anti-C5a monoclonal antibody for the treatment of SARS-CoV-2-induced Acute Respiratory Distress Syndrome (ARDS).
The Paul Ehrlich Institute (PEI) has approved expansion of the global INVISE Phase 1 clinical trial to Europe. The study aims to evaluate first-in-class gene therapy for the treatment of B-cell malignancies.
A US$67.5m Series B financing in XyloCor Therapeutics led by French Jeito Capital will fund two double-blind Phase 2 trials for XC001, a pioneering gene therapy for severe cardiovascular disease.
As part of the 2024 Nobel Prize Week, the prestigious awards have been presented. These include the Nobel Prize in Medicine or Physiology for the discoverers of microRNAs as a new class of regulatory molecules, and the Nobel Prize in Chemistry for AI-supported methods in protein design and the rapid calculation of their structures.
CN Bio, a leading provider of Organ-on-a-chip Systems and solutions that accelerate drug discovery and development workflows, today announced the launch of its PhysioMimix® Bioavailability assay kit: Human 18. Harnessing the capabilities of the PhysioMimix Multi-organ System, the kit enhances lead optimization and preclinical testing pipelines, providing an all-in-one solution to generate predictive insights into human oral bioavailability, and better inform lead candidate selection.
The Strasbourg-based biotech company Transgene and the Berlin-based CDMO ProBioGen have entered into a licensing agreement to collaboratively advance the development of individualised cancer vaccines.
Ultra-low freezers are playing a key role in biomedical research as they are required to store very temperature-sensitive biologicals such as DNA, enzymes and more, but they have high energy demands. Recognizing these issues, B Medical Systems has introduced the U701V, a new ULT freezer that balances energy efficiency with exceptional performance.
Efficiency and flexibility are key factors to stay competitive in the bioprocess field. With this aim in mind, the SciVario twin was envisioned as a tool to save time and costs during process development and optimization. All critical process parameters can be precisely controlled directly at the controller’s touch screen. The device is suitable for microbial and cell culture applications in both glass and single-use bioreactors. The innovative bay-drawer system enables flexible adaptation to unique requirements and changing processes. Frequent updates offered by Eppendorf, such as new functional modules, support for different bioreactor sizes and models, as well as additional software features, will help to enable the SciVario twin to serve your current and future bioprocessing needs.
A total of US$1bn was pledged to the WHO at this year’s World Health Summit in Berlin for the fight against Mpox, Marburg virus and the consequences of climate change.
Since 1995, the Eppendorf Award for Young European Investigators, endowed with €20,000, has honored outstanding achievements in the field of biomedical research in Europe once a year.